LIFE:ATAI

atai Life Sciences

Stock

USD

Last Close

1.52

22/11 21:00

Market Cap

220.98M

Beta: -

Volume Today

2.09M

Avg: -

Overview Metrics Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-24.38M -	-178.63M 632.55%	-174.24M 2.45%	-157.42M 9.66%	-40.22M 74.45%
depreciation and amortization	6K -	24K 300%	47K 95.83%	168K 257.45%	319.00K 89.88%
deferred income tax	7.54M -	56.35M 647.69%	39.13M 30.55%	5.07M 87.03%	-124K 102.44%
stock based compensation	57K -	67.16M 117,721.05%	63.36M 5.65%	42.38M 33.12%	32.98M 22.17%
change in working capital	-126K -	4.45M 3,631.75%	-7.60M 270.88%	-3.33M 56.14%	7.47M 323.96%
accounts receivables					-2.01M -
inventory					2.01M -
accounts payables	249K -	1.70M 584.34%	2.30M 34.98%	-3.03M 231.91%	2.14M 170.47%
other working capital	-375K -	2.75M 832.27%	-9.90M 460.67%	-301K 96.96%	5.33M 1,871.10%
other non cash items	9.06M -	29.88M 229.63%	16.06M 46.26%	8.67M 46.02%	-84.54M 1,075.31%
net cash provided by operating activities	-7.85M -	-20.77M 164.67%	-63.25M 204.57%	-104.47M 65.18%	-84.12M 19.48%
investments in property plant and equipment	-19K -	-59K 210.53%	-1.13M 1,811.86%	-1.02M 9.22%	-590.00K 42.38%
acquisitions net	-456K -	-2.09M 357.89%	-52.94M 2,435.30%		-1 -
purchases of investments	-11.55M -	-23.92M 107.10%	-23.66M 1.10%	-309.66M 1,208.89%	-185.26M 40.17%
sales maturities of investments	10.31M -		-955K -	226.83M 23,852.25%	139.47M 38.51%
other investing activites	-7.32M -	-2.20M 69.89%	-2.60M 17.88%	-3M 15.47%	-6.91M 130.40%
net cash used for investing activites	-9.03M -	-28.27M 213.04%	-81.28M 187.49%	-86.85M 6.86%	-53.29M 38.63%
debt repayment		-32.50M -	-1.59M 95.11%	-13.26M 734.70%	-8.58M 35.27%
common stock issued	42.68M -	82.44M 93.14%	409.88M 397.20%	4.64M 98.87%	225.00K 95.15%
common stock repurchased
dividends paid
other financing activites	-2.29M -	63.12M 2,850.15%	1.57M 97.52%	29.40M 1,777.65%	2 100.00%
net cash used provided by financing activities	40.39M -	113.05M 179.91%	409.86M 262.54%	20.79M 94.93%	-8.35M 140.20%
effect of forex changes on cash	-372K -	3.17M 951.88%	-320K 110.10%	-1.12M 250.94%	189K 116.83%
net change in cash	23.14M -	67.18M 190.34%	265.02M 294.47%	-171.65M 164.77%	-145.58M 15.19%
cash at beginning of period	6.92M -	30.06M 334.30%	97.25M 223.48%	362.27M 272.53%	190.61M 47.38%
cash at end of period	30.06M -	97.25M 223.48%	362.27M 272.53%	190.61M 47.38%	45.03M 76.37%
operating cash flow	-7.85M -	-20.77M 164.67%	-63.25M 204.57%	-104.47M 65.18%	-84.12M 19.48%
capital expenditure	-19K -	-59K 210.53%	-1.13M 1,811.86%	-1.02M 9.22%	-590.00K 42.38%
free cash flow	-7.87M -	-20.82M 164.78%	-64.37M 209.12%	-105.49M 63.87%	-84.71M 19.70%

All numbers in USD (except ratios and percentages)